Latest filing published 06 Jul 2021 for Telo Genomics Corp., €3,392.
No signal scores available.
William John Meekison appears in our data through filings on Telo Genomics Corp. shares, published by SEDI. In total, 3 filings cover trades dated from 27 February 2020 to 2 July 2021.
The open-market record is one-sided, with 1 purchase worth €2,316 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 6 July 2021 came the latest disclosure, a transaction for €3,392 in Telo Genomics Corp. The clock since the last published purchase (28 October 2020) now reads 2,187 days. The median gap between a trade and its publication by SEDI is 4 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations